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0022-2836 © 2006 Elsevier Ltd. Open acceRecent efforts to design de novo or redesign the sequence and structure of
proteins using computational techniques have met with significant success.
Most, if not all, of these computational methodologies attempt to model
atomic-level interactions, and hence high-resolution structural character-
ization of the designed proteins is critical for evaluating the atomic-level
accuracy of the underlying design force-fields. We previously used our
computational protein design protocol RosettaDesign to completely
redesign the sequence of the activation domain of human procarboxypepti-
dase A2. With 68% of the wild-type sequence changed, the designed
protein, AYEdesign, is over 10 kcal/mol more stable than the wild-type
protein. Here, we describe the high-resolution crystal structure and solution
NMR structure of AYEdesign, which show that the experimentally
determined backbone and side-chains conformations are effectively
superimposable with the computational model at atomic resolution. To
isolate the origins of the remarkable stabilization, we have designed and
characterized a new series of procarboxypeptidase mutants that gain
significant thermodynamic stability with a minimal number of mutations;
one mutant gains more than 5 kcal/mol of stability over the wild-type
protein with only four amino acid changes. We explore the relationship
between force-field smoothing and conformational sampling by comparing
the experimentally determined free energies of the overall design and these
focused subsets of mutations to those predicted using modified force-fields,
and both fixed and flexible backbone sampling protocols.© 2006 Elsevier Ltd. Open access under CC BY license.Keywords: Computational protein design; Rosetta; Thermodynamic stabi-
lization; High-resolution protein structure; Procarboxypeptidase A2*Corresponding authorIntroduction
Natural proteins perform a startling diversity of
biological functions, but comprise a miniscule
fraction of the theoretical sequence–structure spacertment of Genetics,
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ss under CC BY license.that polypeptides might occupy.1–4 The goal of
protein design is to identify new free-energyminima
in this sequence–structure landscape so as to expand
the functional repertoire of polypeptides beyond that
observed in nature.5–9 The design of new proteins
should allow for the creation of novel molecular
machines and therapeutics but requires an accurate
description of the forces that govern protein struc-
ture and folding.10,11 The last decade has witnessed
tremendous advances in the development of in silico
protein sequence and structure optimization algo-
rithms. They have been applied successfully to
completely redesign12 and thermodynamically sta-
bilize natural protein folds,13 to create novel14 and
thermodynamically-stabilized enzymes,15 to rede-
sign protein–protein16 and protein–ligand17 interac-
1210 High-resolution Structural Analysis of AYE Designtions, and to create extremely stable novel protein
structures.18,19 While structural validation in a few
cases has confirmed the high-resolution accuracy of
the designs,12,15,16,18–20 the total repertoire of high-
resolution structures of computationally designed
proteins remains small. Structural characterization
of designed proteins is essential for validation of the
design model and for evaluating the accuracy of the
underlying force-fields.
In a large-scale evaluation of our computational
protein design methodology, we used RosettaDe-
sign to completely redesign the sequence of nine
small globular proteins.13 The redesign of the
activation domain of human procarboxypeptidase
A2, AYEdesign, was the most successful redesign; it
had a native-like secondary structure profile, was
rigid and well folded, was stabilized dramatically
over its wild-type counterpart,13 and folded much
faster and unfolded much slower than the wild-type
protein.21 We have now determined high-resolution
crystal and NMR structures of AYEdesign, to
evaluate the atomic-level accuracy of the RosettaDe-
sign protocol. We use the information gleaned from
these structural studies to design and characterize a
new series of AYE mutants that gain significant
thermodynamic stability with a minimal number of
mutations. The analysis of these results provides
insight into the coupling between force-field
smoothing and the extent of conformational sam-
pling in high-resolution protein modeling and
design.Results and Discussion
RosettaDesign was previously used to redesign
completely the sequence of the activation domain of
human procarboxypeptidase A2.13 The 1.8 Å crystal
structure of the wild-type protein (1AYE)22 was
used as a template for the design simulation,
allowing all amino acids except cysteine at all 70
positions. The final sequence chosen for experimen-
tal study, AYEdesign, differed from the wild-type
protein by 68% over all residues and 33% over core
residues. Far-UV circular dichroism (CD) spectros-
copy, 1D 1H nuclear magnetic resonance (NMR)
spectroscopy, and chemical and thermal denatur-
ation experiments showed that AYEdesign adopted
a well-folded, rigid structure, with a secondary
structure profile very similar to that of the wild-type
protein. AYEdesign was found to be extremely
stable; its folded structure is impervious to boiling
and it is greater than 10 kcal/mol more stable than
the wild-type protein (Table 2). It also folds ∼1000-
fold faster and unfolds ∼20,000-fold slower than the
wild-type protein.21 To extend the comparison
between AYEdesign and its wild-type parent to
atomic resolution, we have now determined both
crystal and solution NMR structures of AYEdesign.
We produced and crystallized a selenomethionyl
(SeMet)-substituted variant of AYEdesign (AYE-
des_VJQ), and solved the x-ray crystal structure of
AYEdes_VJQ to a resolution of 2.1 Å by directrebuilding into an unbiased multiple-wavelength
anomalous dispersion (MAD) electron density map
and residual difference Fourier maps. The final
Rwork and Rfree were 0.20 and 0.27, respectively
(Supplementary Data Table S1). The asymmetric
unit of the crystal contains two independent protein
chains. The N-terminal 70 residues of each chain
exhibit the expected procarboxypeptidase fold of the
parent 1AYE design target. The Cα RMSD from the
computational model is 1.68 Å and 1.28 Å for chain
A and B, respectively, and this improves to 1.13 Å
and 0.65 Å when 66 of the 70 residues are considered
for chain A and B, respectively (Figure 2(a)).
Two AYEdes_VJQ monomers associate to form a
dimer in the crystal. Dimerization is mediated, in
part, by the C termini of the two chains, which form
an anti-parallel β-sheet consisting of residues 66–73
from chain A and residues 64–70 from chain B
(Figure 1(a)). However, the contribution of chain A
to the β-sheet includes three residues from the
cleavable linker sequence that are not part of the
designed sequence. Gel-filtration chromatography
studies (data not shown) of the AYEdes_VJQ
construct showed that the protein exists predomi-
nantly as a dimer at 10–100 μM (where thermody-
namic properties of the original AYEdesign
construct were measured), as well as at crystallog-
raphy concentrations (≥1 mM). Since the dimer in
the crystal structure was mediated at least partly by
extra C-terminal residues not considered in the
original design, we prepared a new construct,
AYEdes, with an N-terminal His6 tag followed
only by the 70 designed residues of AYEdesign.
Consistent with our original biophysical character-
ization, the AYEdes protein exists predominantly
as a monomer at concentrations of 10–100 μM as
judged by chromatography, but exhibits partial
dimeric character at higher concentrations
(≥1 mM) (data not shown). Analytical ultracentri-
fugation suggests that AYEdes exists in a monomer–
dimer equilibrium with an estimated Kd of ∼150 μM
(Supplementary Data Figure S1). This weak associa-
tion implies that protein dimerization plays an
insignificant role in the extreme thermodynamic
stabilization of the designed monomer, and that the
dimer dissociates well before the monomer unfolds.
We confirmed this assumption by repeating CD
equilibrium denaturation experiments at multiple
concentrations of AYEdes, where we observe that
the melting curves and unfolding transitions for
5 μM, 50 μM, and 100 μM protein are entirely
coincident. This result allowed us to fit the observed
two-state unfolding of AYEdes as equilibrium
denaturation between folded monomers and un-
folded monomers.
To assess whether removal of the extra C-
terminal tag residues had any impact on the
atomic-level structure of AYEdesign, we deter-
mined the NMR solution structure of the AYEdes
construct. The 1D 1H spectra and 2D 1H-15N
heteronuclear single-quantum coherence (HSQC)
spectra of AYEdes exhibit the features of a well-
folded protein (Figure 4), with well-dispersed NH
Figure 1. AYEdesign X-ray and
NMR structures. (a) The AYE-
design X-ray crystal structure
(AYEdes_VJQ, chain A in light
blue, chain B in dark blue) and
NMR solution structure (AYEdes,
chain A in pink, chain B in red) are
superimposed and shown as rib-
bons. The protein forms a symmet-
ric dimer that buries 740 Å of
surface area of the back-face of the
β-sheet, with a gap volume index of
2.37; these values are close to the
average values observed for hetero-
dimer interactions, but indicate a
weaker interaction than is typical
for homodimers or permanent pro-
tein complexes.52 (b) The top 20
NMRmodels from the final AYEdes
structure calculation are shown as
Cα backbones (different color for
each model). The ensemble pair-
wise RMSD is 0.57(±0.18) Å over
backbone atoms and 1.09(±0.11) Å
over heavy-atoms in residues 3–71
in both subunits.
1211High-resolution Structural Analysis of AYE Designresonances of uniform intensity.13 Protein back-
bone and side-chain assignments were obtained by
standard procedures, as described in Materials and
Methods. The uniform 1H-15N heteronuclear nuclear
Overhauser effect (NOE) values (∼0.75) recorded for
AYEdes indicate a conformationally rigid fold in
solution reflecting the observed thermodynamic
stability of this protein (Supplementary Data Figure
S2). The T1/T2 ratios measured for AYEdes give a
correlation time of 10.64 ns, which is consistent with
homodimeric association under the conditions used
for NMR.23 Notably, the HSQC spectrum contains a
single set of cross-peaks for each NH in the protein,
indicating a fully symmetric association in solution.
Structure determination was conducted in a two-
step process; a partly-automated iterative step
dominated by NOE-derived distance constraints
for generating models of a single subunit of AYEdes,
followed by a second refinement step for building
the symmetric homodimer model using interfacial
NOE constraints obtained from 3D 12C-edited-13C-
filteredNOE spectroscopy (NOESY) data. In the final
calculation, 100 structures (chains A and B) weregenerated from the random-coil conformation. The
20 lowest energy structures (Figure 1(b)) had an
average Cyana24 target function of 2.75(±0.10) Å2
and an ensemble pair-wise root-mean-square devi-
ation (RMSD) of 0.57(±0.18) Å over backbone atoms
and 1.09(±0.11) Å over heavy-atoms in residues 3–71
in both subunits (Supplementary Data Table S2).
There was no distance constraint violated by more
than 0.2 Å, and no angle constraint violated by more
than 1.5°. When the ensemble was analysed with
PROCHECKNMR,25 all dihedral angles were found
in the allowed regions of the Ramachandran plot
(Supplementary Table S2). The Cα RMSD of the
lowest energy AYEdes NMR model from the parent
1AYE crystal structure is 1.51 Å over the 70 designed
residues, and improves to 1.05 Å when only the first
66 of the 70 residues are considered (Figure 2(a)). The
relative rigid-body orientation of the two chains in
the NMR structure is virtually identical with the
AYEdes_VJQ crystal structure (Figure 1(a)). These
combined structural results, together with gel-
filtration analysis, suggest that at high concentra-
tions, AYEdesign self-associates and buries the
Figure 2. Comparison of AYEdesign computational model and experimentally determined structures. (a) Both chains
of AYEdes_VJQ (light and dark blue) and AYEdes (pink and red) are superimposed on the AYEdesign computational
model (green), and are shown as Cα backbones in two orientations (related by a +90° rotation around the vertical axis in
the plane of the page). The Cα RMSD from the computational model is 1.68 Å, 1.28 Å, 1.51 Å, and 1.51 Å for chain A and B
of AYEdes_VJQ and AYEdes, respectively, and this improves to 1.13 Å, 0.65 Å, 1.05 Å and 1.05 Å, respectively, when 66 of
the 70 residues are considered. (b) The two chains in AYEdes_VJQ (light and dark blue) differ notably from each other in
the conformation of the loop containing residues 25–27. The backbone of AYEdes_VJQ chain B in this region is effectively
superimposable with the AYEdesign computational model (green) as well as with the two chains of the AYEdes NMR
structure, but the backbone of AYEdes_VJQ chain A deviates at this point. Interestingly, this corresponds to one of two
points at which an insertion or deletion distinguishes the sequence families of procarboxypeptidase A (the template in this
study) and procarboxypeptidase B; residues 25 and 26 are deleted from the procarboxypeptidase B sequence. The
AYEdes_VJQ chain A backbone in the present structure does not, however, adopt the conformation of procarboxy-
peptidase B observed in PDB entry 1KWM (yellow), where the entire α-helix equivalent to residues 11–24 in the current
sequence is displaced to one side.
1212 High-resolution Structural Analysis of AYE Designsurface-exposed hydrophobic residues on the β-
sheet surface, and the strand-swapping in the C-
terminal tag residues (in AYEdes_VJQ) serves to
strengthen the dimeric interaction.
The superimposed backbones of both the crystal
and NMR structures of AYEdesign and the parent1AYE crystal structure (Figure 2(a)) demonstrate
that RosettaDesign successfully generated a new
amino acid sequence that is compatible with the
AYEwt fold. This global design accuracy is likely a
direct consequence of the highly accurate modeling
of side-chain conformations; most side-chains in the
Figure 3. Atomic-level recovery of designed side-
chain conformations in AYEdesign. The side-chains in
the protein core of the AYEdesign X-ray crystal structure
(AYEdes_VJQ chain B, blue) and NMR solution structure
(AYEdes chain B, red) are effectively superimposable on
the computational model (green). Selected side-chains are
shown as sticks and the protein backbone of the
computational model is shown as cartoon ribbons.
1213High-resolution Structural Analysis of AYE Designcore of the AYEdesign NMR and crystal structures
are superimposable with those selected in the
RosettaDesign computational model (Figure 3).
Indeed 73% of all χ1 angles, 79% of χ2 angles
(when χ1 is also correct), and 67% of χ3 angles
(when χ1 and χ2 are also correct) were recovered
accurately (AYEdes_VJQ_chainB compared to AYE-
des_model; root-mean-square deviation (Supple-
mentary Data Table S3). When only buried
residues are considered, 77%, 100%, and 100% ofχ1, χ2 (when χ1 is also correct), and χ3 (when χ1
and χ2 are also correct) angles, respectively, were
recovered accurately (Supplementary Data Table
S3). A rotamer χ-angle is defined as recovered
accurately if the angular difference from the
compared χ-angle is less than 40°. These statistics
compare favorably to mean rotamer recovery in
side-chain repacking experiments of natural pro-
teins using Rosetta (data not shown).
The atomic-level similarity between the Rosetta-
Design computational model and the experimen-
tally determined high-resolution structures of
AYEdesign suggests that specific computationally
designed atomic-level interactions were directly
responsible for the observed significant increase in
thermodynamic stability. We successfully engi-
neered over 10 kcal/mol of increased stability
over the wild-type AYE protein, while changing
48 out of 70 residues in the design process. How-
ever, in the stabilization of biologically relevant
proteins, the aim is often to gain the maximal
amount of stability with the minimal number of
amino acid substitutions. Could we identify a
smaller subset of the AYEdesign mutations that
would still yield significant stabilization or were the
large number of designed residues synergistically
critical for the observed stabilization ? In addition to
understanding the specific structural reasons behind
the AYEdesign stabilization, this reductionist ap-
proach would provide a route to developing and
parameterizing an automated computational meth-
od for identifying small clusters of stabilizing amino
acid mutations.
Using RosettaDesign and structural inspection of
the experimentally determined AYEdesign and
AYEwt structures, we identified a set of residues
likely to contribute to increased stability. We focused
on designed residues that improve inter-residue
packing (increase in attractive interactions and/or
removal of repulsive interactions) and are likely to
increase the amount of hydrophobic surface area
that is buried upon folding; similar strategies haveFigure 4. 1H-15N HSQC spec-
trum of AYEdes. The HSQC spec-
trum of ∼1 mM 15N-AYEdes in
50 mM potassium phosphate (pH
7.0), 100 mM KCl, recorded at
298 K and 750 MHz. Peaks are
labeled with the one-letter amino
acid code and sequence number,
unlabeled peaks in the upper right
corner of the spectrum correspond
to side-chain NH2 from Gln and
Asn residues.
1214 High-resolution Structural Analysis of AYE Designbeen employed to stabilize proteins by computa-
tional protein design.15,26 In order to generalize our
conclusions about protein stabilization, we catego-
rized mutations in terms of their potential contribu-
tion to inter-helical packing, inter-strand packing,
and helix–strand packing. We used RosettaDesign to
score different combinations of these mutations in
the context of the wild-type protein crystal structure
(1AYE). In the design calculations, sets of one to
three residues were allowed a binary choice between
their AYEwt and AYEdesign sequence identities. All
other amino acids were restricted to their wild-type
sequence identities, but were allowed to repack.
For experimental testing, we chose the five lowest-
energy two-point and three-point mutants according
to the version of RosettaDesign used to select the
original AYEdesign sequence (Rosetta_SmallRadii).
Two additional four-point and five-point mutants
that are combinations of structurally-independent
mutational clusters from the top-scoring mutants
were also selected for experimental characteriza-
tion to assess additivity in stabilization. Designed
mutants N16F_A52W and A52W_V53F are pre-
dicted to improve inter-helical packing, E5V_H42V
and E5V_H42V_R44L are predicted to improve
inter-strand packing, I14V_T40P is predicted to
alleviate a helix–strand inter-atomic clash, F30W is
predicted to improve helix–strand packing, and
E5V_H42V_R44L_F30W and E5V_H42V_R44L_
A52W_V53F test combinations of the other mutants.
The middle column in Figure 5 shows the Rosetta-
Design models of the mutants (yellow) in the context
of their AYEwt structural amino acid neighbors
(colored CPK). The corresponding views of the
AYEwt and AYEdes_VJQ crystal structures are
shown in the left and right columns, respectively.
Site-directed mutagenesis of the AYEwt gene was
used to generate the designed mutants described
above. Like AYEwt andAYEdes, themutant proteins
were over-expressed in Escherichia coli, and purified
to ≥95% homogeneity using Ni-affinity chromatog-
raphy. All mutants were expressed at high levels and
were soluble. The far-UV CD scans of all the mutants
are identical with AYEwt and AYEdes (Figure 6(a)),
suggesting that the mutations did not affect protein
secondary structure significantly. Protein stability
was assessed by following the guanidine hydrochlo-
ride (GuHCl)-induced change of the CD signal. The
free energies of unfolding were estimated from the
excellent fits of the chemical denaturation data
(Figure 6(b)) to a two-state model.
All seven designed mutants were found to be
more stable than AYEwt (Table 2). A52W_V53F and
I14V_T40P were modestly stabilizing with free
energy improvements over wild-type of 0.7 and
0.8 kcal/mol, respectively. The two other two-point
mutants, N16F_A52W and E5V_H42V, showed
increased stabilization with free energy improve-
ments over wild-type of 1.5 and 2.2 kcal/mol,
respectively. The three-point mutant E5V_H42V_
R44L and the five-point combination mutant
E5V_H42V_R44L_A52W_V53F showed dramatic
free-energy improvements of 3.0 kcal/mol and 4.1kcal/mol, respectively. The most dramatic stabili-
zation was observed with the four-point mutant
E5V_H42V_R44L_F30W, which resulted in a free-
energy improvement of 5.2 kcal/mol. In contrast,
the original AYEdesign achieved 10.3 kcal/mol of
stabilization, but 48 residues were changed in the
design process.
These results show that the force-field used to
successfully design the extremely stable AYEdesign
sequence13 is successful also in selecting multiple
smaller subsets of mutants that still confer signifi-
cant increases in stability into AYEwt. However, the
Rosetta force-field has been through significant
changes since the original redesign experiment,
and we were interested in evaluating whether
attempts at improving conformational sampling
and force-field smoothing have resulted in design
protocols that retain their successful predictive
power.
To redesign the sequence of even a small protein,
the size of the sequence–structure space to be
searched is enormous.1–4 A variety of approxima-
tions have been employed to render this problem
computationally tractable. The most common is to
hold the co-ordinates of protein backbone atoms
fixed, and to select residues that stabilize this
conformation; this is often referred to as the “inverse
folding problem”.27 Furthermore, side-chain tor-
sional degrees of freedom are typically restricted to a
discrete set of commonly observed values
(rotamers).28 The limited conformational sampling
afforded by these approximations is coarse relative
to the spatial variation of the Lennard-Jones
potentials used to evaluate the packing of potential
protein structure. This sparse sampling of atomistic
potentials by design algorithms can lead to severe
under-packing of protein cores. It is common
practice to address this difficulty by reducing the
atomic radii used to evaluate packing,12 and in our
original redesign experiment13 we scaled down the
atomic radii in our model to 95% of CHARMM19
values; we call this force-field Rosetta_SmallRadii
(Table 1).
In parallel with our large-scale natural protein
redesign experiment,13 we were also applying
RosettaDesign to create a novel protein fold, a
protein sequence and structure not previously
observed in nature. Because it was unlikely that
any arbitrarily chosen protein backbone would be
designable, it was essential that the design proce-
dure in this case included a search of backbone
conformational space in addition to sequence space.
Accordingly, we incorporated the backbone optimi-
zation component of the high-resolution structure
predictionmodule of Rosetta intoRosetta_SmallRadii,
such that iterations between sequence and back-
bone optimization could proceed under the guid-
ance of the same energy function. This protocol
was initially used to select five novel-topology or
Top sequences for experimental characterization.
While all five Top proteins were quite stable and
appeared to have the correct α/β secondary
structure profiles, they appeared to have somewhat
Figure 5. Recapitulation of RosettaDesign stabilization with minimal mutations in AYE. RosettaDesign models of top-
scoring AYE mutants (side-chains, yellow) in the context of their AYEwt structural amino acid neighbors (side-chains,
CPK) with the AYEwt protein backbone represented in ribbons (olive) are shown in the central column. The
corresponding views of the AYEwt (mutated side-chains, cyan) and AYEdes_VJQ chain B(mutated side-chains, green)
crystal structures are shown in the left and right columns, respectively. The mutations are labeled above the
corresponding illustration in the central column.
1215High-resolution Structural Analysis of AYE Designmolten cores. Speculating that this was the result of
over-packing the protein interior, we increased the
atomic radii to values consistent with high-resolu-
tion crystal structures. With this modification, we
were able to successfully design the Top7 protein;
we found it to be folded and extremely stable
(ΔG°=13.2 kcal/mol), and the X-ray crystal struc-
ture of Top7 showed it to be virtually identical with
the design model (Cα RMSD=1.17Å) at atomic-
resolution.19 We recently showed that de novo
structure prediction of small protein domains was
also improved by the use of this version of theRosetta force-field,29 producing models of hereto-
fore unprecedented accuracy (RMSD <1.5 Å). Con-
sequently, the force-field used for these successes,
termed Rosetta_HardRep (Table 1), became the
default for both protein design and high-resolution
structure prediction in Rosetta. It is important to
note that both of the applications for which this
force-field proved superior incorporate some type
of backbone conformational freedom.
To compare the relative predictive ability of the
old and new Rosetta force-fields in the context of a
fixed protein backbone design simulation, we
Figure 6. Biophysical character-
ization of AYE stabilization recapi-
tulationmutants. (a) The far-UVCD
spectra of 25 μM AYEwt, seven
designedAYEmutants, andAYEdes
in 25mMTris (pH8.0), 50mMNaCl,
at 25 °C. (b) The CD signal at 220 nm
as a function of GuHCl concentra-
tion for all the above proteins at a
concentration 5 μM in 25 mMHCl
(pH 8.0), 50 mM NaCl at 25 °C.
1216 High-resolution Structural Analysis of AYE Designrepeated the AYE mutant design simulations
using Rosetta_SmallRadii and Rosetta_HardRep.
The predicted free energies of these mutants
relative to the wild-type protein are summarized
in Table 2. The Rosetta_SmallRadii force-field was
able to successfully predict the stabilizing effect of
a majority of the designed mutants. In stark
contrast, the Rosetta_HardRep force-field incorrectly
predicted all but two of the mutants to be de-
stabilizing. This supports the idea that tight packing,
when described with coarse conformational sam-
pling but evaluated with a standard molecular
mechanics potential, can yield spurious atom–atom
clashes.We have attempted to reconcile the samplingTable 1. Summary of RosettaDesign force-field variants
Force-field variant
Relative
radii size
Repulsive
treatment
Backbone
flexibility
HardRep – r12 No
SmallRadii < HardRep r12 No
DampRep > HardRep Damped r12 No
FlexBB = HardRep r12 Yes
See Materials and Methods for details.and the evaluation by altering each separately. In the
former case, we have developed a damped variant of
the Lennard-Jones potential, and in the latter we
have expanded the conformational sampling by
introducing limited backbone flexibility.
It has been shown that rotamer libraries must be
supplemented with a large number of extra dihe-
dral–space conformers to sample adequately a
standard Lennard-Jones potential when the back-
bone is held fixed.30 We have taken an alternative
approach by selecting a computationally tractable
rotamer library (and thus a fixed sampling density
in side-chain dihedral space), and adapting our
packing potential to that level of sampling. This
adaptation is necessary to avoid the spurious clashes
that result from a mismatch in resolution between
sampling and evaluation. Previously, the primary
adaptation considered to reduce clashes is a
reduction in atomic radii.12,13 This has the danger
of also shifting the maxima in atom–atom radial
distribution functions (RDFs), resulting in system-
atic deviations from native structures. We have
observed such shifts in large-scale repacking tests
(data not shown). To overcome these problems, we
developed a new force-field, Rosetta_DampRep
Table 2. Observed and computed ΔΔG values (kcal/mol) for AYE mutants
1217High-resolution Structural Analysis of AYE Design(Table 1), in which the Lennard-Jones potential was
modified such that the atom–atom RDFs of struc-
tures repacked under the potential match those
resulting from replacing each side-chain in the
native structure with the rotamer in a given library
that has the lowest heavy-atom coordinate RMSD
from the native side-chain. Thus, we attempted to
match not the native structure, but the best
approximation to the native at a fixed resolution.
Atomic radii were varied empirically to ensure that
maxima in the RDFs of repacked and approximated
structures were in agreement (Supplementary Data
Figure S3). Atomic radii were either held fixed
(typically for polar atoms) or scaled by a factor of
1.07 (typically for non-polar atoms). It is interesting
that, in contrast to common practice, we found that
some radii should be increased and none decreased
to adapt best to the fixed backbone approximation.
Although the scaling term was determined empir-
ically, we speculate that expanded radii may correct
for either “overcompression” due to the small but
finite attractive component of the Lennard-Jones
potential at longer ranges or the omission of thermal
effects in the repacking calculations. Finally, we
empirically selected a “switch point” on the repul-
sive side of the Lennard-Jones curve at which the
potential changes to a linear functional form, with a
slope taken from the tangent at the switch point. A
single value (given as a fraction of the distance to the
potential minimum) was determined for all atom
types, and was selected to match the RDFs between
repacked and approximated native structures at
distances less than the maximum. Although the
Rosetta_DampRep potential was constructed to
match RDFs, we have observed that it also yields
improved performance in side-chain repacking
applications (Supplementary Data Table S4). We
repeated the AYE mutants design simulations using
Rosetta_DampRep, and observed that, similar to
Rosetta_SmallRadii, this new force-field successfully
predicted the stabilizing effect of a majority of the
mutants (Table 2). We were thus able to observe
good design predictions in a fixed-backbone context
using two different methods for damping the
computational evaluation of atomic-overlap inRosetta; either scaling down atomic radii or explic-
itly damping the repulsive component of the
Lennard-Jones potential.
As an alternate approach to using potentials with
damped repulsive terms, we tested whether the
Rosetta_HardRep potential could be used to success-
fully predict the stability of the AYE mutants if the
protein backbone and side-chains were allowed to
relax following mutation. The flexible backbone
protocol, Rosetta_FlexBB (Table 1), begins with
gradient-based minimization of the backbone and
side-chain torsion angles in the wild-type structure.
Mutations are modeled onto the relaxed wild-type
structure and repacked along with neighboring
residues to identify low-energy rotamers. Following
repacking, the backbone and side-chain torsion
angles are minimized once more. The energies of
the relaxed wild-type and mutated structures are
compared to calculate the change in protein stability.
In general, the protein structure does not vary
dramatically with this protocol, backbone devia-
tions are typically less than 0.4 Å RMSD. Indepen-
dent simulations do not produce identical structures
and energies; therefore, 100 simulations were
performed for each mutation and the lowest energy
result was used for comparison. We observed that,
similar to the fixed-backbone Rosetta_SmallRadii and
Rosetta_DampRep force-fields, Rosetta_FlexBB was
able to successfully predict the stabilizing effect of
a majority of the AYE mutations (Table 2).
Despite the overall success of these predictions, the
design search space was restricted in this test, since
the programwas given only a binary choice between
the original AYEwt and AYEdesign sequences. For a
true evaluation of design prediction, all amino acids
should be allowed at the design positions. Accord-
ingly, the protocol with the best ΔΔG° prediction for
AYEdes, Rosetta_DampRep, was used to redesign the
mutated residues in the seven mutants described
above, allowing all 20 amino acids to be chosen at
those positions. Table 3 shows that RosettaDesign
predominantly designs either the same or similar
amino acids as those picked in the binary choice
experiment; E5V, I14T, F30W, T40P,H42V, andA52W
are identical, and N16W and V53Y are similar types
Table 3. Rosetta_DampRep design predictions for AYE stabiliza-
tion recapitulation clusters
1218 High-resolution Structural Analysis of AYE Designof mutations (N16F and V52F in AYEdesign). Only
R44K does not match the AYEdesign trend.
It is instructive to compare the results of our work
with other studies of this protein, since others have
used AYEwt as a subject for rational stabilization
attempts. Villegas et al.31 mutated surface-exposed
residues on the two helices to improve predicted
helical propensity, and reported that two four-point
mutants (one set per helix) stabilized the protein by
1.1 kcal/mol and 1.5 kcal/mol. A combined eight-
point mutant stabilized the protein by 2.8 kcal/mol.
Table 2 shows that RosettaDesign was also able to
successfully predict the stabilizing effects of two out
of three of these mutants.
Conclusion
By solving the crystal and NMR structures of
AYEdesign, we have demonstrated the high-resolu-
tion accuracy of our computational protein design
methodology, RosettaDesign. A comparison of the
experimentally determined structures and our com-
putational model showed that the extreme thermo-
dynamic stabilization of AYEdes was a direct
consequence of atomically accurate modeling of
both backbone and side-chain conformations. We
used the information gleaned from these structural
studies to identify small clusters of residues that can
independently provide significant thermodynamic
stabilization, and showed that RosettaDesign can
successfully predict the stabilizing effect of these
mutations. Finally, we compared different force-
fields and approaches to computing the free-energy
change associated with these stabilizing mutations,
and found that good recapitulation with fixed back-
bone models and coarse sampling around side-chain
rotamers requires either reduced radii or damped
repulsion terms, while the current, more accurate
Rosetta force-field yields good predictions when
used with explicit modeling of backbone flexibility.
Materials and Methods
Protein expression and purification
The computationally designed amino acid sequence of
AYEdesign has been reported.13 Two different expression
constructs that contain the AYEdesign sequence were
prepared.
The first construct (used for crystallography) was a
fusion construct in a pET3a-based vector consisting of an
N-terminal His6 tag, the 70 residues of the AYEdesign
sequence, a 15-residue linker containing a TEV proteasecleavage site, and the C-terminal 62 residues of structural
genomics target sequence Lmaj000047 (geneDB identifier
LmjF25.2320). This construct was prepared to leverage
the excellent stability and solubility of AYEdesign to
potentially improve the solubility of unrelated proteins
that are tagged to it. Cleavage of the expressed fusion
protein by TEV protease should yield one chain
(AYEdes_VJQ) with the N-terminal His6 tag, the AYEde-
sign sequence, and nine C-terminal linker residues from
the TEV cleavage site, and another chain with six N-
terminal linker residues from the TEV cleavage site and the
structural genomics target protein. The fusion protein was
expressed in E. coli BL21 (DE3) in the presence of seleno-
methionine as described,32 and purified using a Ni-NTA
column (Qiagen). The column was washed with His-
tagged TEV protease with the intent of releasing only the
target Lmaj000047 fragment. However, for unknown
reasons, both cleavage fragments were released from the
column and inadvertently carried forward into crystalliza-
tion trials. In any case, the AYEdes_VJQ fragment crystal-
lizedpreferentially and its structurewasdetermined de novo
using multiple-wavelength anomalous diffraction (MAD).
The second construct (used for NMR spectroscopy and
thermodynamic measurements) was in a pet29b-based
vector consisting of an N-terminal His6 tag followed by
the 70 residues of the AYEdesign sequence. This construct
(AYEdes), was expressed in E. coli BL21 (DE3) in LB or M9
minimal medium supplemented with appropriately iso-
tope-labeled NH4Cl and glucose, as needed, and purified
by Ni-affinity chromatography followed by gel-filtration
chromatography. Purified samples contained no impurity
that was detectable by SDS-PAGE.
The wild-type AYE construct (AYEwt) in a pet29b-based
vector was used essentially as described,21 except the C-
terminal His6 tag was moved to the N terminus by PCR
subcloning, to match the AYEdes construct. All mutants
were generated in the context of this construct using the
Quick Change Site-Directed mutagenesis kit (Stratagene).
Crystallographic structure determination
Crystals of AYEdes_VJQ grew from sitting drops
containing 1 μl of protein solution (6.9 mg/ml protein in
20 mM Hepes (pH 7.5), 0.5 M NaCl, 2 mM β-mercap-
toethanol, 5% (v/v) glycerol), 1 μl of crystallization buffer
(20% (w/v) PEG 1000, 40 mM CaCl2, 100 mM sodium
acetate), and 1 μl of crystallization buffer containing
microcrystalline seeds from earlier crystallization trials.
Diffraction data at three wavelengths were collected
from a single crystal on beamline 8.2.1 at the Advanced
Light Source (ALS). Data were integrated and scaled using
the HKL2000 package.33 Essentially the entire backbone of
the two monomers in the crystal asymmetric unit was
auto-traced by the program RESOLVE,34 on the basis of
initial phases derived from four Se sites identified
automatically by SHELXD.35 Automated assignment and
fitting of protein side-chains failed utterly, since at that
point the sequence was still mistakenly expected to match
that of Lmaj000047. Manual inspection of the experimen-
tally phased electron density maps easily assigned
identities for residues making up the eight-residue
sequence MVEWFLEM spanning the two SeMet sites in
each chain. This characteristic sequence fragment revealed
the true identity of the structure to be the AYEdes design
sequence plus the nine linker residues proximal to the TEV
cleavage site (AYEdes_VJQ). The remaining side-chains
were placed using the real-space fit and refine mode of
Xfit.36 Only the first three residues from the linker
sequence in each chain were well-ordered; hence, the
1219High-resolution Structural Analysis of AYE Designfinal crystallographic model contains 73 residues per
chain. The structure was refined at 2.1 Å resolution using
the program REFMAC5,37 yielding standard residuals
Rwork and Rfree of 0.20 and 0.27, respectively (Supplemen-
tary Data Table S1). The stereochemistry and fit to density
of the final model were validated using MolProbity38 and
Coot.39 Of 142 (ϕ,ψ) dihedral angle pairs, 139 are in
favored regions of backbone conformational space, while
the remaining three residues are in allowed regions.
NMR structure determination
Freshly purified samples of AYEdes were concentrated
to ∼1 mM by centrifugation and were prepared for NMR
studies in 8% (v/v) 2H2O or ∼100% 2H 2O containing
50 mM potassium phosphate (pH 7.0) and 100 mM KCl.
NMR experiments were recorded at 298 K on a Bruker
DRX 500 and DMX 750 MHz as well as on a Bruker
500 MHz equipped with cryo-probe (at NMRFAM) and
Varian 600 MHz spectrometers (at PNNL). Combinations
of standard triple-resonance experiments (HNCO, HNCA,
HN(CO)CACB, HNCACB, and HCCH-TOCSY)40 were
used to obtain nearly complete assignments for 72
residues. Heteronuclear 13C and 15N-edited 3D and
homonuclear 2D NOESY experiments collected with
mixing times of 100 ms were used to obtain structural
restraints. Intra-molecular restraints were obtained from
13C-filtered chirp-NOESY data collected at PNNL with a
mixing time of 100ms on the 600MHzVarian spectrometer
equipped with a cryo-probe. Spectra were processed using
NMRPipe,41 and analyzed with Sparky†. 1H,15N-Hetero-
nuclear NOE, T1 and T2 relaxation experiments were all
collected on the Bruker DRX 500 MHz spectrometer and
analyzed using ModelFree.42 NOE assignments and
structure calculations for the AYEdes monomeric subunit
were performed initially using combined automated and
manual methods in CYANA.24 Assigned inter-molecular
NOE restraints were duplicated for chains A and B of the
AYEdes symmetric homodimer and intra-molecular NOE
restraints were derived from 13C-filtered chirp-NOESY
data. Torsion angle restraintswere included forϕ/ψ angles
according to TALOS predictions,43 and hydrogen bonding
constraintswere derived fromamide 2H2Oprotectiondata.
Structure calculations for AYEdes were completed with
CYANA v2.1 and visualized using MOLMOL.44 Analysis
with PROCHECK found 100% of the residues for AYEdes
in allowed regions of the Ramachandran plot.45 Structural
statistics from 20/100 lowest energy structures (chains A
and B) are provided (Supplementary Data Table S2).
Size-exclusion (gel-filtration) chromatography
Size-exclusion chromatography was carried out using
an analytical Superdex-75 column (Amersham Pharmacia)
with the Pharmacia FPLC system (GP-250 gradient
programmer, P-500 Pump). Protein samples at concentra-
tions used for NMR (600 μM–1.2 mM) or CD (5–100 μM)
were equilibrated in 25 mM Tris– HCl (pH 8.0), 20 mM
EDTA, 50 mMNaCl at 25 °C, and run on the Superdex-750
column at a flow-rate of 1 ml/min.
Analytical ultra-centrifugation
Sedimentation equilibrium studies on AYEdes were
conducted in a Beckman XL-A analytical ultracentrifuge† http://www.cgl.ucsf.edu/home/sparky/using six-channel 12 mm Epon charcoal-filled center-
pieces. All scans were conducted at 20 °C using an
absorbance wavelength of 280 nm at rotor speeds of
25,000 rpm, 35,000 rpm, and 45,000 rpm. AYEdes
concentrations were determined from a scan at 3000 rpm
to be 13 μM, 33 μM, and 50 μM. Data were collected in
25 mM Tris–HCl (pH 8.0), 50 mM NaCl with and without
20 mM EDTA. The effect of EDTA on the associative state
of AYEdes was negligible. Equilibration for 8 h was
deemed sufficient by identical absorbance scans collected
after 6 h and 8 h at each speed.
The UltraScan software package was used for data
analysis as well as deriving solvent density and partial
specific volume parameters‡. The weight-averaged mo-
lecular mass, MW, was determined for individual equilib-
rium scans by fitting to a single ideal species model using
non-linear least-squares analysis. Residuals to the fit were
random, and the fitted values for the baseline offset agreed
well with values determined using the meniscus-depletion
method. Next, global fits were performed for each protein
concentration across the three speeds to determine MW at
each concentration. Amonomer–dimer equilibriummodel
was used to determine the dissociation constant. Confi-
dence limits were determined by Monte Carlo analysis
with UltraScan.
Circular dichroism (CD)
CD data were collected on an Aviv 62A DS spectrom-
eter. Far-UV CD wavelength scans (260–195 nm) at 25 °C
were collected in a 1 mm path-length cuvette. Guanidi-
nium hydrochloride (GuHCl)-induced protein denatur-
ation was followed by the change in ellipticity at 220 nm in
a 1 cm path-length cuvette, using a Microlab titrator
(Hamilton) for denaturant mixing. Temperature was
maintained at 25 °C with a Peltier device. All CD data
were converted to mean residue ellipticity. To obtain a
value for ΔGU
H2O, the denaturation curves were fit by non-
linear least-squares analysis using a linear extrapolation
model.46
Computational procedure
Our method for computational protein design, Rosetta-
Design, has been described in detail.13,19 In brief,
RosettaDesign contains two main components; an energy
function that ranks the relative fitness of amino sequences
for a given protein structure and a Monte Carlo
optimization procedure for rapidly searching sequence
space. The energy function is a linear combination of a 6-
12 Lennard-Jones potential, the Lazaridis–Karplus implicit
solvation model,47 an empirical hydrogen bonding
potential,48 backbone-dependent rotamer probabilities,49
amino acid probabilities for particular regions of ϕ/ψ
space, and a simple electrostatics pseudo-energy derived
from the distance distributions of polar residues in the
PDB.50 In addition, each amino acid has a unique reference
energy that provides an implicit treatment of the unfolded
state and enforces a native-like sequence composition.
Weights for the various energy terms were determined as
described.51 Briefly, all rotamers from a backbone-depen-
dent library are placed at each position in a set of proteins.
Each energy component is calculated for each rotamer
with the remainder of the protein held fixed. The energy
terms form the coefficients of a matrix; an optimal vector‡ www.ultrscan.uthscsa.edu
1220 High-resolution Structural Analysis of AYE Designof weights is obtained such that the energy gap between
native and non-native rotamers is maximized. These
weights are then used to redesign fully the training set
of proteins. The weights are again optimized, now using
the redesigned proteins, rather than the native proteins, as
the context in which the energy matrix is determined. The
procedure is iterated through ∼5 cycles of weight
optimization and full redesign before the weights con-
verge. This process compensates for the fact that the
weight determination step makes a linearizing approxi-
mation to the full design problem when it calculates
rotamer energies in an otherwise unchanged background.
Four variants of the general RosettaDesign force-field
were employed in this study (Table 1). In the version of
RosettaDesign used to select the original AYEdesign
sequence (Rosetta_SmallRadii),13 the atomic radii were
scaled by 0.95 relative to standard CHARMM 19 radii.
The damped repulsive variant of RosettaDesign (Rosetta_
DampRep) differs from standard RosettaDesign in its
treatment of the Lennard-Jones potential in the repulsive
region (where atom–atom energies are greater than zero).
At distances less than a specified fraction of the energy
minimum, the potential takes on a linear form, with its
slope selected to match that of the Lennard-Jones potential
at that distance. Additionally, atomic radii are scaled by a
constant factor; a factor of 1.07 was found empirically to
improve agreement between the atom–atom distance
distribution maxima observed in native crystal structures
and the same structures when side-chain positions were
repacked using RosettaDesign. Both Rosetta_SmallRadii
and Rosetta_DampRep keep the co-ordinates of the protein
backbone fixed during the design simulation. In a third
variant of RosettaDesign, the protein backbone was
allowed to relax following a mutation. This protocol
(Rosetta_FlexBB) begins with relaxing the wild-type
structure with gradient-based minimization of side-chain
and backbone torsion angles using an energy function that
has full-size radii and a standard representation of the
Lennard-Jones potential. This relaxed structure is used to
calculate the energy of the wild-type sequence and is used
as the template for making mutations. The energy of the
mutant structure is determined by repacking the residues
surrounding the site of mutation followed by gradient-
based minimization of backbone and side-chain torsion
angles. As a control for the above RosettaDesign variants,
a fourth protocol (Rosetta_HardRep) uses the Rosetta_
FlexBB force-field with standard atomic radii and Len-
nard-Jones potential, while keeping the protein backbone
fixed during design simulations.PDB accession codes
X-ray coordinates and structure factors have been
deposited with the PDB as accession code 1vjq. NMR
Coordinates and experimental constraint files have been
deposited with the PDB as accession code 2gjf.Acknowledgements
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